Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: SGLT2I, . Treffer: 14
2025
Muhs, T; Ljubojevic-Holzer, S; Sattler, S
Anti-inflammatory Therapies for Ischemic Heart Disease.
Curr Cardiol Rep. 2025; 27(1): 57
Doi: 10.1007/s11886-025-02211-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Valenzuela, Ripoll, C; Lotfinaghsh, A; Guo, Z; Kumari, T; Miyata, KN; Sargazi, A; Ozcan, M; Diab, A; Ataran, A; Hajirezaei, H; Rashidi, O; Yu, W; Cho, Y; Kovacs, A; Weinheimer, C; Nigro, J; Cases, O; Kozyraki, R; Oscarsson, J; Esterline, R; Levi, M; Berger, JH; Schilling, JD; Apte, RS; Sardiello, M; Peikert, A; Kosiborod, M; Adamo, L; Lowenstein, C; Christoffersen, C; Cho, J; Javaheri, A
Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans.
JACC Adv. 2025; 4(6 Pt 2):101839
Doi: 10.1016/j.jacadv.2025.101839
PubMed
FullText
FullText_MUG
2024
Aziz, F; Tripolt, NJ; Pferschy, PN; Scharnagl, H; Abdellatif, M; Oulhaj, A; Benedikt, M; Kolesnik, E; von, Lewinski, D; Sourij, H
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.
Cardiovasc Diabetol. 2024; 23(1): 145
Doi: 10.1186/s12933-024-02221-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Benedikt, M; Oulhaj, A; Rohrer, U; Manninger, M; Tripolt, NJ; Pferschy, PN; Aziz, F; Wallner, M; Kolesnik, E; Gwechenberger, M; Martinek, M; Nürnberg, M; Roithinger, FX; Steinwender, C; Widkal, J; Leiter, S; Zirlik, A; Stühlinger, M; Scherr, D; Sourij, H; von, Lewinski, D
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.
NEJM Evid. 2024; 3(10):EVIDoa2400147
Doi: 10.1056/EVIDoa2400147
PubMed
FullText
FullText_MUG
Caravaca-Fontán, F; Stevens, K; Padrón, M; Huerta, A; Montomoli, M; Villa, J; González, F; Vega, C; López, Mendoza, M; Fernández, L; Shabaka, A; Rodríguez-Moreno, A; Martín-Gómez, A; Labrador, PJ; Molina, Andújar, A; Prados, Soler, MC; Martín-Penagos, L; Yerovi, E; Medina, Zahonero, L; De, La, Flor, JC; Mon, C; Ibernon, M; Rodríguez, Gómez, A; Miquel, R; Sierra, M; Mascarós, V; Luzardo, L; Papasotiriou, M; Arroyo, D; Verdalles, Ú; Martínez-Miguel, P; Ramírez-Guerrero, G; Pampa-Saico, S; Moral, Berrio, E; Canga, JLP; Tarragón, B; Fraile, Gómez, P; Regidor, D; Relea, J; Xipell, M; Andrades, Gómez, C; Navarro, M; Álvarez, Á; Rivas, B; Quintana, LF; Gutiérrez, E; Pérez-Valdivia, MÁ; Odler, B; Kronbichler, A; Geddes, C; Anders, HJ; Floege, J; Fernández-Juárez, G; Praga, M
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis.
Nephrol Dial Transplant. 2024; 39(2):328-340
Doi: 10.1093/ndt/gfad175
Web of Science
PubMed
FullText
FullText_MUG
Halimi, JM; Sarafidis, P; Azizi, M; Bilo, G; Burkard, T; Bursztyn, M; Camafort, M; Chapman, N; Cottone, S; de, Backer, T; Deinum, J; Delmotte, P; Dorobantu, M; Doumas, M; Dusing, R; Duly-Bouhanick, B; Fauvel, JP; Fesler, P; Gaciong, Z; Gkaliagkousi, E; Gordin, D; Grassi, G; Grassos, C; Guerrot, D; Huart, J; Izzo, R; Jaén, Águila, F; Járai, Z; Kahan, T; Kantola, I; Kociánová, E; Limbourg, F; Lopez-Sublet, M; Mallamaci, F; Manolis, A; Marketou, M; Mayer, G; Mazza, A; MacIntyre, I; Mourad, JJ; Muiesan, ML; Nasr, E; Nilsson, P; Oliveras, A; Ormezzano, O; Paixão-Dias, V; Papadakis, I; Papadopoulos, D; Perl, S; Polónia, J; Pontremoli, R; Pucci, G; Robles, NR; Rubin, S; Ruilope, LM; Rump, LC; Saeed, S; Sanidas, E; Sarzani, R; Schmieder, R; Silhol, F; Sokolovic, S; Solbu, M; Soucek, M; Stergiou, G; Sudano, I; Tabbalat, R; Tengiz, I; Triantafyllidi, H; Tsioufis, K; Václavík, J; van, der, Giet, M; der, Niepen, PV; Veglio, F; Venzin, R; Viigimaa, M; Weber, T; Widimsky, J; Wuerzner, G; Zelveian, P; Zebekakis, P; Lueders, S; Persu, A; Kreutz, R; Vogt, L
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney.
Blood Press. 2024; 33(1):2368800
Doi: 10.1080/08037051.2024.2368800
Web of Science
PubMed
FullText
FullText_MUG
Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19):
Doi: 10.3390/jcm13195966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sourij, C; Aziz, F; Tripolt, NJ; Siller-Matula, J; Pferschy, PN; Kolesnik, E; Wallner, M; Eyileten, C; Postula, M; Oulhaj, A; Sourij, H; von Lewinski, D; EMMY study group
Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trial.
Hellenic J Cardiol. 2024; 75: 3-8.
Doi: 10.1016/j.hjc.2023.05.007
Web of Science
PubMed
FullText
FullText_MUG
2023
Aziz, F; Tripolt, NJ; Pferschy, PN; Kolesnik, E; Mangge, H; Curcic, P; Hermann, M; Meinitzer, A; von, Lewinski, D; Sourij, H, , EMMY, Investigators
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial.
Cardiovasc Diabetol. 2023; 22(1): 184
Doi: 10.1186/s12933-023-01920-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Osto, E; Bonacina, F; Pirillo, A; Norata, GD
Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanisms.
Pharmacol Res. 2023; 188: 106667
Doi: 10.1016/j.phrs.2023.106667
Web of Science
PubMed
FullText
FullText_MUG
von, Lewinski, D; Kolesnik, E; Aziz, F; Benedikt, M; Tripolt, NJ; Wallner, M; Pferschy, PN; von, Lewinski, F; Schwegel, N; Holman, RR; Oulhaj, A; Moertl, D; Siller-Matula, J; Sourij, H
Timing of SGLT2i initiation after acute myocardial infarction.
Cardiovasc Diabetol. 2023; 22(1): 269
Doi: 10.1186/s12933-023-02000-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Wicik, Z; Nowak, A; Jarosz-Popek, J; Wolska, M; Eyileten, C; Siller-Matula, JM; von, Lewinski, D; Sourij, H; Filipiak, KJ; Postuła, M
Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis.
Front Pharmacol. 2022; 13: 901340
Doi: 10.3389/fphar.2022.901340
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Hecking, M; Sharif, A; Eller, K; Jenssen, T
Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics.
Transpl Int. 2021; 34(1):27-48
Doi: 10.1111/tri.13783
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
von, Lewinski, D; Benedikt, M; Tripolt, N; Wallner, M; Sourij, H; Kolesnik, E
Can sodium-glucose cotransporter 2 inhibitors be beneficial in patients with acute myocardial infarction?
Kardiol Pol. 2021; 79(5):503-509
Doi: 10.33963/KP.15969
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG